CC BY-NC-ND 4.0 · Journal of Social Health and Diabetes 2015; 03(01): 048-051
DOI: 10.4103/2321-0656.140892
Original Article
NovoNordisk Education Foundation

Medication adherence and determinants of non-adherence among south Indian diabetes patients

Ravi Kumar Medi
1   Department of Pharmacy Practice and Pharm D, St. Peter′s Institute of Pharmaceutical Sciences, Kakatiya University, Warangal, Andhra Pradesh, India
,
Uday Venkat Mateti
1   Department of Pharmacy Practice and Pharm D, St. Peter′s Institute of Pharmaceutical Sciences, Kakatiya University, Warangal, Andhra Pradesh, India
2   Manipal College of Pharmaceutical Sciences, Manipal University, Manipal, Karnataka, India
,
Krishna Reddy Kanduri
3   Department of General Medicine, Rohini Super Specialty Hospital, Warangal, Andhra Pradesh, India
,
Shiv Sagar Konda
2   Manipal College of Pharmaceutical Sciences, Manipal University, Manipal, Karnataka, India
› Author Affiliations
Further Information

Publication History

Publication Date:
21 November 2018 (online)

Abstract

Objectives: The objective of the study is to determine the adherence and determinants of non-adherence among diabetes patients. Materials and Methods: A cross-sectional observation study was conducted for a period of six months in both inpatients and outpatients of diabetic clinic at a super speciality hospital. The structured medication adherence questionnaire (MAQ) was administered to the eligible diabetic patients to assess the adherence rate and determinants of non-adherence. Results: During the study period, a total of 140 patients were enrolled. Out of 140 patients, most of them were females (n = 79, 56.57%), than males (n = 61, 43.57%). Among them (n = 49, 35%) patients were in the age group greater than or equal to 61 years followed by (n = 42, 30%) patients between 51-60 years and others. The overall medication adherence rate was found to be 47.85%. The main factors for non-adherence were lack of finance (n = 43, 55.84%), forgetfulness (n = 36, 46.75%), being busy (n = 34, 44.15%), medicines inaccessibility (n = 15, 19.48%) and others. Conclusion: The overall medication adherence rate was found to be unsatisfactory. The main challenging factors affecting medication adherence were lack of finance, forgetfulness, being busy, medicines inaccessibility and side effects of drugs.

 
  • References

  • 1 Cramer JA, Roy A, Burrell A, Fairchild CJ, Fuldeore MJ, Ollendorf DA. et al. Medication compliance and persistence: Terminology and definitions. Value Health 2008; 11: 44-7
  • 2 Akari S, Mateti UV, Kunduru BR. Health-care cost of diabetes in South India: A cost of illness study. J Res Pharm Pract 2013; 2: 114-117
  • 3 Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care 2004; 27: 1218-1224
  • 4 Lawrence D, Ragucci KR, Long LB, Parris BS, Helfer LA. Relationship of oral antihyperglycemic (sulfonylurea or metformin) medication adherence and hemoglobin A1C goal attainment for HMO patients enrolled in a diabetes disease management program. J Manag Care Pharm 2006; 12: 466-471
  • 5 Schectman JM, Nadkarni MM, Voss JD. The association between diabetes metabolic control and drug adherence in an indigent population. Diabetes Care 2002; 25: 1015-1021
  • 6 Krapek K, King K, Warren SS, George KG, Caputo DA, Mihelich K. et al. Medication adherence and associated hemoglobin A1C in type 2 diabetes. Ann Pharmacother 2004; 38: 1357-1362
  • 7 Lee WC, Balu S, Cobden D, Joshi AV, Pashos CL. Prevalence and economic consequences of medication adherence in diabetes: A systematic literature review. Manag Care Interface 2006; 19: 31-41
  • 8 Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care 2005; 43: 521-530
  • 9 World Health Organization, diabetes mellitus fact sheet, number 238. 2002 Available from: http://www.who.int/chp/knowledge/publications/adherence_full_report.pdf [Last Accessed on 2012 Nov 10].
  • 10 Wabe NT, Angamo MT, Hussein S. Medication adherence in diabetes mellitus and self management practices among type-2 diabetics in Ethiopia. N Am J Med Sci 2011; 3: 418-423
  • 11 Grant RW, Devita NG, Singer DE, Meigs JB. Polypharmacy and medication adherence in patients with type 2 diabetes. Diabetes Care 2003; 26: 1408-1412
  • 12 Santhosh YL, Naveen MR. Medication adherence behavior in chronic diseases like asthma and diabetes mellitus. Int J Pharm Pharm Sci 2011; 3: 238-240
  • 13 Isomaa B, Almgren P, Tuomi T, Forsén B, Lahti K, Nissén M. et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24: 683-689
  • 14 Haynes RB, McKibbon KA, Kanani R. Systematic review of randomized trials of interventions to assist patients to follow prescriptions for medications. Lancet 1996; 348: 383-386
  • 15 Graves MM, Roberts MC, Rapoff M, Boyer A. The efficacy of adherence interventions for chronically ill children: A meta-analytic review. J Pediatr Psychol 2010; 35: 368-382
  • 16 Rolnick S, Pawloski P, Bruzek R, Hedblom B, Asche S, Fustgaard M. et al. PS2-32: Barriers and facilitators for medication adherence. Clin Med Res 2011; 9: 157
  • 17 Vervloet M, Linn AJ, van Weert JC, de Bakker DH, Bouvy ML, van Dijk L. The effectiveness of interventions using electronic reminders to improve adherence to chronic medication: A systematic review of the literature. J Am Med Inform Assoc 2012; 19: 696-704
  • 18 Dayer L, Heldenbrand S, Anderson P, Gubbins PO, Martin BC. Smartphone medication adherence apps. J Am Pharm Assoc 2013; 53: 172-181